Tag: Biotechnology | Page 16 | NAI 500 | Page 16

- English
  - 简体中文
  - 繁體中文

Home
Biotechnology

Filter

Short-Term Rate Breach Flags Tight U.S. Dollar Plumbing

Sep 16, 2025

Netskope hikes IPO range; NTSK targets $7.3B debut

Sep 16, 2025

CVC circles Avendus as Mizuho stalls, markets take note

Sep 15, 2025

CRISPR Therapeutics Soars as Partner Vertex Drops Optimistic 2026 Sales Guidance

Three CRISPR Stocks You Can’t Afford to Miss

Sep 14, 2025

Adobe Results Risk Cementing AI Laggard Status as Stock Slides

Sep 11, 2025

Rasonque's Lightning Approval Validates Druckenmiller's Bet on Revolution Medicines

AbbVie’s ‘Patent Playbook’ Powers 494% Return, Fuels Dividend Surge

Sep 8, 2025

Qualcomm Surges 15% as OpenAI Speculation and Data Center Business Fuel Rally

Wall Street Analysts: The Bull Case for These High-Flying Healthcare Stocks

Sep 7, 2025

Three Biotech Stocks Crushed the S&P 500 — Analysts Still Back Just One

How Viking and Axsome Stocks Could Double by 2030

Sep 5, 2025

Sharp (6753) Reenters Vinyl With RP-TT100 Bluetooth

Sep 4, 2025

US Seizure of Chinese Precursors Risks Sanctions Spiral

Sep 4, 2025

Tariffs Tax Consumers, Narratives Set the Bill

Sep 3, 2025

Inflation Forces Fed U-Turn: Rate Hikes Are Now Inevitable

Pfizer’s 7% Dividend Yield: A Cause for Investor Concern?

Sep 2, 2025

From Stabilizer to Stress Point: The Perils of Taxing Remittances

Sep 2, 2025

Caterpillar targets RPMGlobal in A$1.1b tech push

Sep 1, 2025

China’s Cash Collateral Exposes a Hidden Seniority Trap

Aug 29, 2025

This Cathie Wood-Favored Gene-Editing Stock Is Up 47% This Year. Is It Poised to Take Off?

Investment Guide to Genetics Stocks and ETFs

Aug 28, 2025

Baozun Q2 miss tests China brand ecommerce model

Aug 28, 2025

Down 46%, Yet Wall Street Predicts a 161% Surge: Would You Bet on This Weight-Loss Drug Stock?

Billionaire Druckenmiller and Analysts Bet on Viking Therapeutics as Next GLP-1 Dark Horse

Aug 27, 2025